Neurokinin A in rat adjuvant arthritis. Effect of capsaicin treatment

NeuroReport

Volumn 10, Issue 16, 1999, Pages 3307-3313

  Spetea, Mariana ^a   Ahmed, Mahmood ^a,d   Bileviciute Ljungar, Indre ^b   Lundeberg, Thomas ^b   Schultzberg, Marianne ^c   Kreicbergs, Andris ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KUS Huddinge   (Sweden)

^d AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

Ankle joints; Arthritis; Capsaicin; Dorsal root ganglia; Immunohistochemistry; Neurokinin A; Neuropeptide; Radioimmunoassay; Rat; Sensory neurons

Indexed keywords

CAPSAICIN; NEUROKININ A;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANKLE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; IMMUNOHISTOCHEMISTRY; NEUROCHEMISTRY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RADIOIMMUNOASSAY; RAT; SENSORY NERVE; SPINAL GANGLION;

EID: 0032739305     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199911080-00011     Document Type: Article

References (24)

1. 1. Wilder RL. Annu Rev Immunol 13, 307-338 (1995).
2. 2. Levine, JD, Clark R, Doever M et al. Science 226, 547-549 (1984).
3. 3. Ahmed M, Bjurholm A, Schultzberg M et al. Arth Rheum 38, 699-709 (1995).
4. 4. Imai S, Tokunaga Y and Konttinen YT. J Rheumatol 24, 2177-2187 (1997).
5. 5. Elhassan AM, Lindgren Ju, Hultenby K and Adem A. J Bone Miner Res 14, 73-79 (1999).
6. 6. Strand FL. Tachykinins: Substance P, neurokinin A, and neurokinin B. In: Stevens CF, ed. Neuropeptides. Regulators of Physiological Processes. Massachusetts: MIT Press, 1999:365-381.
7. 7. Dugan AW, Hendry IA. Morton CR et al. Brain Res 451, 261-273 (1995).
8. 8. Regoli D, Drapeau G, Dion S and D'Orleans-Juste P. Life Sci 40, 109-117 (1967).
9. 9. D'Orleans-Juste P, Dion S, Mizrahi J and Regoli D. Eur J Pharmacol 114, 9-21 (1985).
10. 10. Nantel F, Rouissl N, Rhaleb NE et al. Eur J Pharmacol 179, 457-462 (1990).
11. 11. Tousignant C, Dion S, Drapeau G and Regoli D. Neuropeptides 9, 333-343 (1987).
12. 12. Ahmed A, Bjurholm A, Srinivasan GR et al. Reg Pept 55, 85-102 (1995).
13. 13. Ahmed M, Bjurholm A, Srinivasan GP et al. Peptides 15, 317-322 (1994).
14. 14. Theodorsson-Norheim E. Computer Methods Prog Biomed 26, 207-214 (1988).
15. 15. Levine JD, Dardick SJ, Roizen MF et al. J Neurosci 6, 3432-3429(1986).
16. 16. Bjurholm A, Kreicbergs A, Ahmed M and Schultzberg M. Arth Rheum 33, 859-865 (1990).
17. 17. Krause JE, Chirgwin JM, Carter MS et al. Proc Natl Acad Sci USA 84, 881-885 (1987).
18. 18. Donaldson LF, Harmar AJ, McQueen DS and Seckl JR. Mol Brain Res 16, 143-149 (1992).
19. 19. Donnerer J, Schuligoi R and Stein C. Neuroscience 49, 693-698 (1992).
20. 20. Aloe L, Tuveri MA, Carcassl U and Levi-Montalcini R. Arth Rheum 35, 351-355 (1992).
21. 21. Kimball ES, Persico FJ and Vaughl JL. Immunology 141, 3564-3569 (1988).
22. 22. Tsuji F, Hamada M and Scirasawa E. Ocular Immunol Inflamm 6, 19-25 (1998).
23. 23. Lippi A, Santicioli P, Criscuoli M and Maggi CA. Naunyn-Schmiedeberg's Arch Pharmacol 357, 245-251 (1998).
24. 24. Mantyh PW, Catton MD, Boehmer CG et al. Peptides 10, 627-645 (1989).